Howard B. Lassman

612 total citations
28 papers, 466 citations indexed

About

Howard B. Lassman is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Howard B. Lassman has authored 28 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in Howard B. Lassman's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Blood properties and coagulation (3 papers) and Synthetic Organic Chemistry Methods (3 papers). Howard B. Lassman is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Blood properties and coagulation (3 papers) and Synthetic Organic Chemistry Methods (3 papers). Howard B. Lassman collaborates with scholars based in United States, Austria and Canada. Howard B. Lassman's co-authors include Surendra K. Puri, Irwin Ho, Julian L. Ambrus, James T. Doluisio, Robert V. Smith, Irving B. Mink, Clara M. Ambrus, Jason D. Coombes, Jeffrey C. Wilker and Richard C. Allen and has published in prestigious journals such as Journal of Applied Physiology, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Howard B. Lassman

28 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard B. Lassman United States 13 149 93 67 45 43 28 466
Sydney H. Dromgoole United States 16 138 0.9× 74 0.8× 142 2.1× 30 0.7× 49 1.1× 31 711
H Vergin Switzerland 11 177 1.2× 81 0.9× 79 1.2× 19 0.4× 74 1.7× 56 544
Nils‐Olov Bodin Sweden 10 86 0.6× 69 0.7× 58 0.9× 24 0.5× 65 1.5× 12 392
Heather A. Friedel 10 149 1.0× 197 2.1× 145 2.2× 54 1.2× 57 1.3× 11 797
Charles L. Woronick United States 15 106 0.7× 176 1.9× 64 1.0× 18 0.4× 46 1.1× 37 578
S. C. Sharma India 17 72 0.5× 98 1.1× 73 1.1× 95 2.1× 53 1.2× 50 769
B J Crump United Kingdom 8 244 1.6× 156 1.7× 159 2.4× 35 0.8× 67 1.6× 9 816
John S. Wold United States 14 236 1.6× 97 1.0× 33 0.5× 14 0.3× 70 1.6× 24 448
Adnan El‐Yazigi Saudi Arabia 15 110 0.7× 94 1.0× 36 0.5× 19 0.4× 26 0.6× 60 597
K Kumano Japan 11 88 0.6× 138 1.5× 32 0.5× 14 0.3× 47 1.1× 40 396

Countries citing papers authored by Howard B. Lassman

Since Specialization
Citations

This map shows the geographic impact of Howard B. Lassman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard B. Lassman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard B. Lassman more than expected).

Fields of papers citing papers by Howard B. Lassman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard B. Lassman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard B. Lassman. The network helps show where Howard B. Lassman may publish in the future.

Co-authorship network of co-authors of Howard B. Lassman

This figure shows the co-authorship network connecting the top 25 collaborators of Howard B. Lassman. A scholar is included among the top collaborators of Howard B. Lassman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard B. Lassman. Howard B. Lassman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simpson, Kate, et al.. (1996). Multiple-Dose Pharmacokinetics of Pentoxifylline and its Metabolites during Renal Insufficiency. Annals of Pharmacotherapy. 30(7-8). 724–729. 20 indexed citations
2.
Nix, David E., et al.. (1992). Cerebrospinal fluid penetration of cefpirome in patients with non-inflamed meninges. Journal of Antimicrobial Chemotherapy. 29(suppl A). 51–57. 11 indexed citations
3.
Lassman, Howard B., et al.. (1992). Lack of interaction between cefpirome and alcohol. Journal of Antimicrobial Chemotherapy. 29(suppl A). 47–50. 4 indexed citations
4.
Fischer, Peter, W Danielczyk, K. A. Jellinger, et al.. (1991). Clinico pathological classification of dementia. Der Nervenarzt. 62(7). 408–414. 1 indexed citations
5.
Puri, Surendra K., et al.. (1990). Multiple Dose Pharmacokinetics, Safety, and Tolerance of Velnacrine (HP 029) in Healthy Elderly Subjects: A Potential Therapeutic Agent for Alzheimer's Disease. The Journal of Clinical Pharmacology. 30(10). 948–955. 23 indexed citations
6.
Puri, Surendra K., et al.. (1989). Single Dose Safety, Tolerance, and Pharmacokinetics of HP 029 in Healthy Young Men: A Potential Alzheimer Agent. The Journal of Clinical Pharmacology. 29(3). 278–284. 23 indexed citations
7.
Lassman, Howard B., et al.. (1988). Pharmacokinetics of Roxithromycin (RU 965). The Journal of Clinical Pharmacology. 28(2). 141–152. 26 indexed citations
8.
Lassman, Howard B., et al.. (1988). Pharmakodynamik und Pharmakokinetik des neuen H2-Rezeptorantagonisten Roxatidinacetat nach multiplen Dosen bei gesunden Männern. Drugs. 35(Supplement 3). 53–64. 9 indexed citations
9.
Puri, Surendra K. & Howard B. Lassman. (1987). Roxithromycin: a pharmacokinetic review of a macrolide. Journal of Antimicrobial Chemotherapy. 20(suppl B). 89–100. 81 indexed citations
10.
Smith, Robert V., et al.. (1986). Pharmacokinetics of Orally Administered Pentoxifylline in Humans. Journal of Pharmaceutical Sciences. 75(1). 47–52. 86 indexed citations
11.
Helsley, Grover C., et al.. (1977). Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 1. 6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acids. Journal of Medicinal Chemistry. 20(1). 66–70. 12 indexed citations
12.
Lassman, Howard B., et al.. (1977). Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 2. Dihydro-10-oxofuro- and -thieno[3,2-c][1]benzoxepin-8-acetic acids. Journal of Medicinal Chemistry. 20(3). 456–458. 7 indexed citations
13.
Lassman, Howard B. & Nathan Back. (1974). BIOCHEMICAL PHARMACOLOGY OF THE FIBRINOLYSIN SYSTEM OF THE RAT. III. THE MECHANISM OF PHENFORMIN [1-(β-PHENETHYL)- BIGUANIDE]-INDUCED FIBRINOLYTIC ACTIVITY. Journal of Pharmacology and Experimental Therapeutics. 189(2). 333–343. 1 indexed citations
14.
Lassman, Howard B., et al.. (1974). BIOCHEMICAL PHARMACOLOGY OF THE FIBRINOLYSIN SYSTEM OF THE RAT. I. THE EFFECT OF ALLOXAN-INDUCED HYPERGLYCEMIA. Journal of Pharmacology and Experimental Therapeutics. 189(2). 317–326. 3 indexed citations
15.
Lassman, Howard B., et al.. (1974). Alterations in platelet aggregation associated with adjuvant arthritis in rats. Pharmacological Research Communications. 6(5). 493–507. 2 indexed citations
16.
Ambrus, J L, George Schimert, Thomas Z. Lajos, et al.. (1971). Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.. PubMed. 2(2). 65–81. 28 indexed citations
17.
Ambrus, Clara M., Julian L. Ambrus, Kenneth R. Niswander, et al.. (1970). Changes in Fibrin-stabilizing Factor Levels in Relation to Maternal Hemorrhage and Neonatal Disease. Pediatric Research. 4(1). 82–88. 8 indexed citations
18.
Ambrus, Clara M., Julian L. Ambrus, Howard B. Lassman, & Irving B. Mink. (1968). STUDIES ON THE MECHANISM OF ACTION OF INHIBITORS OF THE FIBRINOLYSIN SYSTEM*. Annals of the New York Academy of Sciences. 146(2). 430–447. 30 indexed citations
19.
Ambrus, Julian L., et al.. (1967). Absorption of exogenous and endogenousproteolytic enzymes. Clinical Pharmacology & Therapeutics. 8(3). 362–368. 26 indexed citations
20.
Munson, Albert E., et al.. (1964). Quantitative evaluation of fibrinolytic enzymes in a simulated human system. Journal of Applied Physiology. 19(3). 536–539. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sydney H. Dromgoole Breakdown of academic impact, for papers by H Vergin Breakdown of academic impact, for papers by Nils‐Olov Bodin Breakdown of academic impact, for papers by Heather A. Friedel Breakdown of academic impact, for papers by Charles L. Woronick Breakdown of academic impact, for papers by S. C. Sharma Breakdown of academic impact, for papers by B J Crump Breakdown of academic impact, for papers by John S. Wold Breakdown of academic impact, for papers by Adnan El‐Yazigi Breakdown of academic impact, for papers by K Kumano
Rankless by CCL
2026